232 related articles for article (PubMed ID: 31884405)
21. Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats.
Pan M; Deng Y; Qiu Y; Pi D; Zheng C; Liang Z; Zhen J; Fan W; Song Q; Pan J; Li Y; Yan H; Yang Q; Zhang Y
Phytomedicine; 2024 Jul; 130():155712. PubMed ID: 38763008
[TBL] [Abstract][Full Text] [Related]
22. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ
Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892
[TBL] [Abstract][Full Text] [Related]
23. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
[TBL] [Abstract][Full Text] [Related]
24. Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway.
Tian L; Chen J; Yang M; Chen L; Qiu J; Jiang Y; Tan X; Qian Q; Liang X; Dou X
Phytomedicine; 2024 Aug; 131():155776. PubMed ID: 38851104
[TBL] [Abstract][Full Text] [Related]
25. Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK.
Du J; Zhang M; Lu J; Zhang X; Xiong Q; Xu Y; Bao Y; Jia W
Endocrine; 2016 Sep; 53(3):701-9. PubMed ID: 26994931
[TBL] [Abstract][Full Text] [Related]
26. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
27. The hepatoprotective effects of Sedum sarmentosum extract and its isolated major constituent through Nrf2 activation and NF-κB inhibition.
Wang GW; Zhang XL; Wu QH; Jin YB; Ning CT; Wang R; Mao JX; Chen M
Phytomedicine; 2019 Feb; 53():263-273. PubMed ID: 30668406
[TBL] [Abstract][Full Text] [Related]
28. Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease.
Al Humayed S
Arch Physiol Biochem; 2017 Feb; 123(1):23-30. PubMed ID: 27424611
[TBL] [Abstract][Full Text] [Related]
29. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.
Yuan Y; Naito H; Jia X; Kitamori K; Nakajima T
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906458
[TBL] [Abstract][Full Text] [Related]
30. Baicalin improved hepatic injury of NASH by regulating NRF2/HO-1/NRLP3 pathway.
Shi H; Qiao F; Lu W; Huang K; Wen Y; Ye L; Chen Y
Eur J Pharmacol; 2022 Nov; 934():175270. PubMed ID: 36184988
[TBL] [Abstract][Full Text] [Related]
31. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
[TBL] [Abstract][Full Text] [Related]
32. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice.
Wayal V; Hsieh CC
Biomed Pharmacother; 2023 Dec; 168():115724. PubMed ID: 37852102
[TBL] [Abstract][Full Text] [Related]
33. Melatonin induces Nrf2-HO-1 reprogramming and corrections in hepatic core clock oscillations in Non-alcoholic fatty liver disease.
Joshi A; Upadhyay KK; Vohra A; Shirsath K; Devkar R
FASEB J; 2021 Sep; 35(9):e21803. PubMed ID: 34365685
[TBL] [Abstract][Full Text] [Related]
34. Butein induction of HO-1 by p38 MAPK/Nrf2 pathway in adipocytes attenuates high-fat diet induced adipose hypertrophy in mice.
Wang Z; Ka SO; Lee Y; Park BH; Bae EJ
Eur J Pharmacol; 2017 Mar; 799():201-210. PubMed ID: 28213287
[TBL] [Abstract][Full Text] [Related]
35. Aescin can alleviate NAFLD through Keap1-Nrf2 by activating antioxidant and autophagy.
Yu H; Yan S; Jin M; Wei Y; Zhao L; Cheng J; Ding L; Feng H
Phytomedicine; 2023 May; 113():154746. PubMed ID: 36905866
[TBL] [Abstract][Full Text] [Related]
36. Hepatoprotective effect of dihydroxy piperlongumine in high cholesterol-induced non-alcoholic fatty liver disease zebrafish via antioxidant activity.
Haridevamuthu B; Seenivasan B; Priya PS; Muthuraman S; Kumar RS; Manikandan K; Almutairi BO; Almutairi MH; Arokiyaraj S; Gopinath P; Arockiaraj J
Eur J Pharmacol; 2023 Apr; 945():175605. PubMed ID: 36822456
[TBL] [Abstract][Full Text] [Related]
37. PIM1 alleviated liver oxidative stress and NAFLD by regulating the NRF2/HO-1/NQO1 pathway.
Yang K; Yu X; Guo Z; Fang Z; Zhang H; Zhang W; Liu C; Ji Y; Dong Z; Gu Q; Yao J; Liu C
Life Sci; 2024 Jul; 349():122714. PubMed ID: 38735366
[TBL] [Abstract][Full Text] [Related]
38. Niga-ichigoside F1 ameliorates high-fat diet-induced hepatic steatosis in male mice by Nrf2 activation.
Xia SF; Shao J; Zhao SY; Qiu YY; Teng LP; Huang W; Wang SS; Cheng XR; Jiang YY
Food Funct; 2018 Feb; 9(2):906-916. PubMed ID: 29309075
[TBL] [Abstract][Full Text] [Related]
39. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats.
Yao X; Xia F; Tang W; Xiao C; Yang M; Zhou B
J Ethnopharmacol; 2018 Feb; 212():208-215. PubMed ID: 29031784
[TBL] [Abstract][Full Text] [Related]
40. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
